March 13, 2024 – Medtronic plc. shared a strong set of latest medical and real-world information on the MiniMed™ 780G System from all over the world, together with the biggest set of information from early adopters in america. The information was introduced on the 17e Worldwide Convention on Superior Applied sciences and Therapies for Diabetes (ATTD) in Florence, Italy. These outcomes construct on the three-year information revealed in Diabetes expertise and remedy displaying that over 100,000 actual customers achieved a Time in Vary (TIR) of 78% utilizing the really useful optimum settings, outperforming the worldwide targets of 70% TIR.
New information was sought to guage the MiniMed™ 780G System's potential to assist customers obtain Time in Tight Vary (TITR) objectives, a brand new and rising complementary measure being mentioned amongst specialists that measures glucose ranges in higher displays folks with out diabetes.
Be taught extra